Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN7 | P35236 | 5/20 | 0.61 |
| ▸ | HMGCR | P04035 | 3/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | RECQL | P46063 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11071774 | 1.00 | PTPN7 (0.61) | PTPN7HMGCRTSHRTHRBRECQL | |
| SCHEMBL11175213 | 1.00 | PTPN7 (0.61) | PTPN7HMGCRTSHRTHRBRECQL | |
| SCHEMBL513302 | 1.00 | PTPN7 (0.61) | PTPN7HMGCRTSHRTHRBRECQL | |
| SCHEMBL9374800 | 1.00 | PTPN7 (0.61) | PTPN7HMGCRTSHRTHRBRECQL | |
| SCHEMBL11066113 | 1.00 | PTPN7 (0.61) | PTPN7HMGCRTSHRTHRBRECQL | |
| SCHEMBL23040316 | 1.00 | PTPN7 (0.61) | PTPN7HMGCRTSHRTHRBRECQL | |
| SCHEMBL9211891 | 1.00 | PTPN7 (0.61) | PTPN7HMGCRTSHRTHRBRECQL | |
| SCHEMBL1523678 | 1.00 | PTPN7 (0.61) | PTPN7HMGCRTSHRTHRBRECQL | |
| SCHEMBL10796010 | 1.00 | PTPN7 (0.61) | PTPN7HMGCRTSHRTHRBRECQL | |
| SCHEMBL513614 | 1.00 | PTPN7 (0.61) | PTPN7HMGCRTSHRTHRBRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2181763-B1 | Catalyst and process for alkoxylation | SHELL INT RESEARCH (NL) | 2012-06-20 | — | — | EP | claimed |
| EP-4748965-A2 | FORMULATIONS FOR SELECTIVE DEPOSITION | Merck Patent GmbH (DE) | 2026-05-27 | — | — | EP | disclosed |
| EP-4743602-A1 | FORMULATIONS FOR SELECTIVE DEPOSITION | Merck Patent GmbH (DE) | 2026-05-20 | — | — | EP | disclosed |
| EP-4707426-A2 | HIGH-PURITY ALKYNES FOR SELECTIVE DEPOSITION | Merck Patent GmbH (DE) | 2026-03-11 | — | — | EP | disclosed |
| US-12503760-B2 | Methods of using high-purity alkynes for selective deposition | MERCK PATENT GMBH (DE) | 2025-12-23 | — | — | US | disclosed |
| US-20250115992-A1 | HIGH-PURITY ALKYNES FOR SELECTIVE DEPOSITION | MERCK PATENT GMBH (DE) | 2025-04-10 | — | — | US | disclosed |
| WO-2025036804-A1 | FORMULATIONS FOR SELECTIVE DEPOSITION | MERCK PATENT GMBH (DE) | 2025-02-20 | — | — | WO | disclosed |
| EP-4482816-A1 | HIGH-PURITY ALKYNES FOR SELECTIVE DEPOSITION | Merck Patent GmbH (DE) | 2025-01-01 | — | — | EP | disclosed |
| CN-118620806-B | Enterobacter pseudo-He and application thereof | 青岛科技大学 | 2024-10-11 | — | — | CN | disclosed |
| CN-118742531-A | High purity alkynes for selective deposition | 默克专利股份有限公司 | 2024-10-01 | — | — | CN | disclosed |
| US-5603074-A | SOLVENT EXTRACTION THE NUCLEAR WASTE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1997-02-11 | — | — | US | disclosed |
| EP-0421441-B1 | Pantothenic acid derivatives | FUJIREBIO KK (JP) | 1995-01-25 | — | — | EP | disclosed |
| US-5120738-A | Cardiovascular disorders | FUJIREBIO INC. (JP) | 1992-06-09 | — | — | US | disclosed |
| EP-0421441-A2 | Pantothenic acid derivatives | FUJIREBIO INC. (JP) | 1991-04-10 | — | — | EP | disclosed |
| EP-0006130-B1 | PROCESS FOR THE CATALYTIC PREPARATION OF POLYMERS OR COPOLYMERS OF ALPHA-OLEFINS HAVING A HIGH ISOTACTICITY INDEX, AND COMPOSITION BASED ON TITANIUM CHLORIDE SUITABLE AS COMPONENT OF THE CATALYTIC SYSTEMS USED IN THIS PROCESS | ATO CHIMIE (FR) | 1982-12-08 | — | — | EP | disclosed |
| US-4287093-A | BY USING A CATALYST MADE FROM TITANIUM TRICHLORIDE OR TETRACHLORIDE AND AN ORGANOALUMINUM COMPOUND, AND CONTAINING A CROWN COMPOUND AS A STEREOSPECIFICITY ADDITIVE | ATO CHIMIE (FR) | 1981-09-01 | — | — | US | disclosed |
| US-4259208-A | STEREOSPECIFICITY ADDITIVE CONTAINING SULFIDE AND ETHER LINKAGES | ATO CHEMIE (FR) | 1981-03-31 | — | — | US | disclosed |
| US-4228252-A | STEREOSPECIFIC ADDITIVE OF A SULFIDE AND ETHER COMPOUND | ATO CHIMIE (FR) | 1980-10-14 | — | — | US | disclosed |
| US-4228253-A | STEREOSPECIFIC CROWN ETHER ADDITIVE AND AN ACTIVATOR HAVE A SYNERGISTIC EFFECT | ATO CHIMIE (FR) | 1980-10-14 | — | — | US | disclosed |
| EP-0006130-A1 | Process for the catalytic preparation of polymers or copolymers of alpha-olefins having a high isotacticity index, and composition based on titanium chloride suitable as component of the catalytic systems used in this process | ATO CHIMIE (FR) | 1980-01-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250115992-A1 | HIGH-PURITY ALKYNES FOR SELECTIVE DEPOSITION | ALK, NTRK1, ALKBH2 | PTPN7 1435/4885HMGCR 735/4885TSHR 4118/4885 |
| US-12503760-B2 | Methods of using high-purity alkynes for selective deposition | ALK, ALKBH2, ALKBH3 | PTPN7 1617/4885HMGCR 314/4885TSHR 4123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.